|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print June 21, 2002
J Appl Physiol, 10.1152/jap.00191.2002
Submitted on March 8, 2002
Accepted on June 6, 2002
1 Department of Biochemistry and Molecular Biology, University of Maryland Medical School, Baltimore, Maryland, USA
2 Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
* To whom correspondence should be addressed. E-mail: ebucci{at}umaryland.edu.
The clinical utility of cross-linked tetrameric hemoglobin solutions is limited by peripheral vasoconstriction thought to be due to scavenging of nitric oxide. In addition, transfusion of crude preparations of hemoglobin polymers can cause arterial hypertension. We tested the hypothesis that eliminating low molecular weight components from the polymer solution would prevent extravasation and its associated pressor response. A zero-link polymer of bovine hemoglobin was developed without chemical linkers left between the tetramers. Transfusion of unprocessed preparations of these polymers in rats resulted in appearance of the polymer in the renal hilar lymph. However, eliminating the low molecular weight components with a 300 kDa diafiltration resulted in an average hydrodynamic radius of 250 angstroms and in undetectable levels of polymer in hilar lymph. Exchange transfusion in anesthetized rats and cats and in awake cats produced no increase in arterial pressure. In anesthetized cats, exchange transfusion with an albumin solution reduced hematocrit from 30 to 18% increased cerebral blood flow and dilated pial arterioles. In contrast, reducing hematocrit by transfusing the diafiltered polymer did not increase cerebral blood flow as pial arterioles constricted. These results are consistent with the hypothesis that the increase in arterial pressure associated with cell-free hemoglobin transfusion depends upon hemoglobin extravasation. Constriction observed in the cerebrovascular bed with a non-extravasating hemoglobin polymer at low hematocrit is presumably a regulatory response to prevent overoxygenation at low blood viscosity.
This article has been cited by other articles:
![]() |
P. Cabrales, G. Sun, Y. Zhou, D. R. Harris, A. G. Tsai, M. Intaglietta, and A. F. Palmer Effects of the molecular mass of tense-state polymerized bovine hemoglobin on blood pressure and vasoconstriction J Appl Physiol, November 1, 2009; 107(5): 1548 - 1558. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cao, L.-C. Wang, H. Kwansa, R. J. Roman, D. R. Harder, and R. C. Koehler Endothelin rather than 20-HETE contributes to loss of pial arteriolar dilation during focal cerebral ischemia with and without polymeric hemoglobin transfusion Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1412 - R1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mito, M. Nemoto, H. Kwansa, K. Sampei, M. Habeeb, S. J. Murphy, E. Bucci, and R. C. Koehler Decreased Damage From Transient Focal Cerebral Ischemia by Transfusion of Zero-Link Hemoglobin Polymers in Mouse Stroke, January 1, 2009; 40(1): 278 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Qin, H. Kwansa, E. Bucci, S. Dore, D. Boehning, D. Shugar, and R. C. Koehler Role of heme oxygenase-2 in pial arteriolar response to acetylcholine in mice with and without transfusion of cell-free hemoglobin polymers Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R498 - R504. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Natanson, S. J. Kern, P. Lurie, S. M. Banks, and S. M. Wolfe Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death: A Meta-analysis JAMA, May 21, 2008; 299(19): 2304 - 2312. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sakai, A. Sato, K. Masuda, S. Takeoka, and E. Tsuchida Encapsulation of Concentrated Hemoglobin Solution in Phospholipid Vesicles Retards the Reaction with NO, but Not CO, by Intracellular Diffusion Barrier J. Biol. Chem., January 18, 2008; 283(3): 1508 - 1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Tsai, P. Cabrales, B. N. Manjula, S. A. Acharya, R. M. Winslow, and M. Intaglietta Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers Blood, November 15, 2006; 108(10): 3603 - 3610. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nemoto, T. Mito, W. S Brinigar, C. Fronticelli, and R. C. Koehler Salvage of focal cerebral ischemic damage by transfusion of high O2-affinity recombinant hemoglobin polymers in mouse J Appl Physiol, May 1, 2006; 100(5): 1688 - 1691. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Kim-Shapiro, A. N. Schechter, and M. T. Gladwin Unraveling the Reactions of Nitric Oxide, Nitrite, and Hemoglobin in Physiology and Therapeutics Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 697 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rebel, S. Cao, H. Kwansa, S. Dore, E. Bucci, and R. C. Koehler Dependence of acetylcholine and ADP dilation of pial arterioles on heme oxygenase after transfusion of cell-free polymeric hemoglobin Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1027 - H1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Qin, H. Kwansa, E. Bucci, R. J. Roman, and R. C. Koehler Role of 20-HETE in the pial arteriolar constrictor response to decreased hematocrit after exchange transfusion of cell-free polymeric hemoglobin J Appl Physiol, January 1, 2006; 100(1): 336 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Azarov, K. T. Huang, S. Basu, M. T. Gladwin, N. Hogg, and D. B. Kim-Shapiro Nitric Oxide Scavenging by Red Blood Cells as a Function of Hematocrit and Oxygenation J. Biol. Chem., November 25, 2005; 280(47): 39024 - 39032. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sampei, J. A. Ulatowski, Y. Asano, H. Kwansa, E. Bucci, and R. C. Koehler Role of nitric oxide scavenging in vascular response to cell-free hemoglobin transfusion Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1191 - H1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Soma, C. E. Uboh, F. Guan, Y. Luo, P. J. Moate, R. C. Boston, and B. Driessen The Pharmacokinetics of Hemoglobin-Based Oxygen Carrier Hemoglobin Glutamer-200 Bovine in the Horse Anesth. Analg., June 1, 2005; 100(6): 1570 - 1575. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Dull, B. J. DeWitt, R. Dinavahi, L. Schwartz, C. Hubert, N. Pace, and C. Fronticelli Quantitative assessment of hemoglobin-induced endothelial barrier dysfunction J Appl Physiol, November 1, 2004; 97(5): 1930 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kavdia and A. S. Popel Contribution of nNOS- and eNOS-derived NO to microvascular smooth muscle NO exposure J Appl Physiol, July 1, 2004; 97(1): 293 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rebel, J. A. Ulatowski, H. Kwansa, E. Bucci, and R. C. Koehler Cerebrovascular response to decreased hematocrit: effect of cell-free hemoglobin, plasma viscosity, and CO2 Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1600 - H1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Bobofchak, T. Mito, S. J. Texel, A. Bellelli, M. Nemoto, R. J. Traystman, R. C. Koehler, W. S. Brinigar, and C. Fronticelli A recombinant polymeric hemoglobin with conformational, functional, and physiological characteristics of an in vivo O2 transporter Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H549 - H561. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |